Insider Stock Trading History of Vanlent Anne


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Vanlent Anne since year 2005. The trader's CIK number is 1229243. At the time of this reporting, Vanlent Anne is the Director of Nabi Biopharmaceuticals . (stock ticker symbol NABI). See this page for all insider trading activities at Nabi Biopharmaceuticals .

Note that in the past VANLENT ANNE also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Vanlent Anne since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-06-22 BOTA Nabi Biopharmaceuticals Buy 35,000 2.20 76,895
2014-05-08 AEGR Aegerion Pharmaceuticals, Inc. Buy 4,000 34.27 137,092
2011-01-13 IART Integra Lifesciences Holdings Corp Sale 5,270 47.49 250,277
2011-01-13 IART Integra Lifesciences Holdings Corp Option Ex 7,500 33.32 249,900

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vanlent Anne (Director of Nabi Biopharmaceuticals at the time of this reporting) see the Securities and Exchange Commission (SEC) website.